Modernizing Nuclear Plants And SMR Advances Will Create Future Opportunities

Key Takeaways

• Expansion in nuclear power and new digital solutions are driving stable, high-margin growth and broadening recurring revenue streams.
  
• Financial flexibility from capital structure optimization supports further acquisitions, technology investments, and enhanced cash generation.
  
• Heavy reliance on nuclear sector and acquisitions exposes Mirion to market, integration, and regulatory risks, challenging its revenue growth and long-term earnings stability.

Catalysts

Provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific.

• The accelerating global shift toward expanded nuclear power generation, coupled with rising capital budgets for modernization, life extensions, and increased capacity of the existing reactor fleet, is likely to drive sustained double-digit organic revenue growth and expand Mirion's higher-margin installed base business in coming years.
  
• Strong momentum in advanced nuclear projects-including utility-scale new builds and rapid activity in the small modular reactor (SMR) market-has materially broadened Mirion's pipeline of large, multi-year opportunities, creating potential for significant step-changes in future order intake, backlog, and top-line revenue.
  
• Heightened focus on regulatory compliance, radiation safety, and operational efficiency-both in the nuclear and wider healthcare sectors-is resulting in recurring demand for Mirion's specialized detection, monitoring, and dosimetry solutions, supporting stable, visible revenue streams and improved customer retention.
  
• Continued rollout of new digital platforms, such as the Vital and Apex-Guard software, along with the strategic Certrec acquisition (bringing SaaS-based, AI-enabled compliance tools), positions Mirion to capture premium pricing, drive software mix expansion, and unlock operating leverage, benefitting margins and long-term earnings potential.
  
• Recent investment in capital structure optimization has reduced interest expense and increased financial flexibility, enabling additional M&A and technology investments while freeing up cash flow that may be deployed to accretive growth initiatives or returned to shareholders, improving net margin and cash generation over time.

Mirion Technologies Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming Mirion Technologies's revenue will grow by 7.9% annually over the next 3 years.
• Analysts assume that profit margins will increase from 1.1% today to 6.1% in 3 years time.
• Analysts expect earnings to reach $68.3 million (and earnings per share of $0.26) by about August 2028, up from $10.0 million today. The analysts are largely in agreement about this estimate.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 92.7x on those 2028 earnings, down from 449.0x today. This future PE is greater than the current PE for the US Electronic industry at 23.0x.
• Analysts expect the number of shares outstanding to grow by 1.2% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.57%, as per the Simply Wall St company report.

Mirion Technologies Future Earnings Per Share Growth

Risks

• Revenue concentration in the nuclear sector exposes Mirion to long-term risks from a shrinking pipeline of new nuclear builds, especially in Western markets, where regulatory, political, and financial challenges may limit future addressable market expansion, potentially capping long-term revenue growth.
  
• The emphasis on modernization and life extension of existing nuclear reactors is positive now, but reliance on aging fleets means that decommissioning, policy shifts, or anti-nuclear sentiment could reverse these trends, introducing structural volatility and long-term demand uncertainty for Mirion's core products, risking future revenue and earnings.
  
• Mirion's acquisition-led growth strategy, including the recent Certrec purchase, increases execution and integration risks-failure to realize expected synergies or elevated SG&A expenses may compress net margins and dilute earnings quality over the long term.
  
• Expanding investment in new digital and AI-driven solutions is necessary to maintain competitiveness, but escalating competition from low-cost international suppliers and technology commoditization could erode Mirion's pricing power, compressing margins and impacting long-term profitability.
  
• The medical and Labs & Research segments are vulnerable to government budgetary pressures (e.g., DOGE, Medicaid cuts), while broader healthcare shifts toward alternative, radiation-free imaging technologies could reduce long-term demand for Mirion's products, weighing on diversified revenue and future earnings stability.

Valuation

• The analysts have a consensus price target of $22.2 for Mirion Technologies based on their expectations of its future earnings growth, profit margins and other risk factors.
  
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $1.1 billion, earnings will come to $68.3 million, and it would be trading on a PE ratio of 92.7x, assuming you use a discount rate of 8.6%.
  
• Given the current share price of $21.47, the analyst price target of $22.2 is 3.3% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.